Showing results (1-10 of 7,246) with videos related to
Sort By:
Pageof 725
Journal of the American Pharmacists Association : Japha|March 21, 2026
Performance validation of large language models for drug-drug interaction consultations: Potential pharmacist assistant in outpatient pharmaceutical servicesHaoran Zhang, Anlin Wang, Cuiping He, et al.Frontiers in Oncology|February 7, 2022
Cutaneous Toxicity Associated With Enfortumab Vedotin: A Real-Word Study Leveraging U.S. Food and Drug Administration Adverse Event Reporting SystemHui Yang, Xiaojia Yu, Zhuoling AnExpert Opinion on Drug Safety|August 16, 2024
Tacrolimus related diabetic ketoacidosis and hyperglycaemic hyperosmolar nonketotic syndrome: an observational, retrospective, pharmacovigilance studyXin Wang, Hui Yang, Zhuoling AnExpert Opinion on Drug Safety|December 23, 2024
Skin cancer associated with calcineurin inhibitors treatment: analysis of FAERS databaseYuezhen Zhu, Hui Yang, Zhuoling AnExpert Opinion on Drug Safety|August 16, 2024
Catatonia related to tacrolimus: a real world pharmacovigilance study of FDA adverse event reporting system (FAERS) databaseJing Yang, Hui Yang, Zhuoling AnExpert Opinion on Drug Safety|August 23, 2023
Urinary tract infection following the use of BTK inhibitors: a real-world analysis of post-marketing surveillance dataHui Yang, Zhexin Ding, Zhuoling AnClinical Therapeutics|August 28, 2023
Bleeding Complications in Vancomycin-Induced Thrombocytopenia: A Real-world Postmarketing Pharmacovigilance AnalysisHui Yang, Ying Zhang, Xin Feng, et al.Clinical Therapeutics|May 10, 2024
Tacrolimus Related Acute Pancreatitis: An Observational, Retrospective, Pharmacovigilance StudyHui Yang, Zhuoling An, Yong Zhao, et al.Clinical Therapeutics|December 17, 2024
Thrombotic Microangiopathy Associated with Calcineurin Inhibitors: A Real-World Analysis of Postmarketing Surveillance DataXin Yu, Yi Zhang, Zhuoling An, et al.Expert Opinion on Drug Safety|April 17, 2024
Immune checkpoint inhibitor related myositis: an observational, retrospective, pharmacovigilance studyHui Yang, Zhexin Ding, Zhuoling An, et al.Pageof 725